MONROVIA, Calif., Nov. 8, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will participate in the Stephens Fall Investment Conference at the New York Palace Hotel in New York City. STAAR's presentation will be on Wednesday, November 14, 2012, at 9:00 am Eastern Time.
Barry G. Caldwell, President and CEO, will review the company's recent financial results and current business developments. Deborah Andrews, CFO, will also be attending.
STAAR will offer a live audio webcast of the roundtable discussion of the business on the Company's website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com or call 626-303-7902.
Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.
Douglas Sherk, 415-652-9100
Jamar Ismail, 415-568-9348
Jenifer Kirtland, 415-568-9349
SOURCE STAAR Surgical Company